← Eichor
Study identifier: NCT03344276 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessing Neurocognition After Cerebrovascular Intervention

Condition: Carotid Artery Diseases · Neurocognitive Dysfunction  ·  Sponsor: University of California, San Diego

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of inflammation, and through neuroimaging at two points before intervention (2 months and 1 month before stenting) and at two points after intervention (1 month and 2 months after intervention). The goal is to provide prospective evidence to identify the extent to which carotid stenosis and hypoperfusion of the brain results in diminished neurocognitive performance, and see if serum biomarkers before and after stenting correlate with these findings.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Khalessi, MD  ·  (619) 543-5540  ·  akhalessi@ucsd.edu

ARVIN WALI, BA, MAS  ·  7149282722  ·  AWALI@UCSD.EDU

Always discuss trial participation with your own doctor first.

Locations (1)

UCSD Medical CenterSan Diego, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03344276